Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New therapy aims to curb youth suicide in ERs

NCT ID NCT06225661

Symptom relief Sponsor: The Hospital for Sick Children Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This trial tests a 6-week therapy program for youth (ages 12-17) who come to the emergency department with suicidal thoughts or behaviors. The program involves weekly sessions with a therapist for the teen and their family. Researchers want to see if this focused approach reduces suicide attempts and repeat ER visits compared to usual care. The study includes 330 participants across three Canadian hospitals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
SAFE Intervention (a 6-week therapy program for youth and their families)
What this could lead to
If it works, this could provide an effective early intervention to reduce suicide attempts and hospital visits in high-risk youth.
What could go wrong
This is a relatively small trial (330 participants) and the intervention is behavioral, so results may vary and may not apply to all youth or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 330 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2021

Expected to finish

Dec 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Youth presenting in the Emergency Department with SIQ-Jr score ≥ 31, * Has a participating parent or caregiver who is able to communicate easily in English, or is willing to communicate using a hospital-organized translator, * Between the ages 12-17 years old, * Living in the catchment area of one of the three hospital sites and access to a telephone. Exclusion Criteria: * Score of 3 on KSADS screen for current psychosis or elevated mood * Moderate to severe intellectual disability, and/or autism based on clinical chart.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Behavioral symptoms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Behavioral Symptoms Self-Injurious Behavior Suicidal Ideation Suicide Suicide Prevention Suicide, Attempted

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Behavioral symptoms Self-injurious behavior Suicidal ideation Suicide Suicide and self-harm Suicide prevention Suicide, attempted

Contacts and locations

Locations

  • Alberta Children's Hospital - Alberta Health Services & University of Calgary

    Calgary, Alberta, T2W 1S7, Canada

  • McMaster Children's Hospital - Hamilton Health Sciences

    Hamilton, Ontario, L8L 8E7, Canada

  • The Hospital for Sick Children

    Toronto, Ontario, M5G 1X8, Canada

  • Trillium Health Partners

    Mississauga, Ontario, L5B 1B8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.